Related Experiment Video
Updated: Oct 23, 2025

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Rationale and proposed framework for shared decision making in cardio-oncology
Sarah C Hull1,2, Aaron Soufer3, Erica S Spatz3,4
1Section of Cardiovascular Medicine, Yale School of Medicine, 20 York Street, New Haven, CT, 06510, USA. sarah.hull@yale.edu.
Shared decision making (SDM) in cardio-oncology helps patients with advanced cancer navigate complex treatment choices. This approach ensures patient values guide decisions for optimal outcomes.
Area of Science:
- Cardio-oncology
- Medical Ethics
- Shared Decision Making
Background:
- Physicians must provide rational guidance on diagnostic and therapeutic options, respecting patient values and goals.
- Cardio-oncology patients with advanced malignancy often feel overwhelmed or lack favorable treatment options.
- Shared decision making (SDM) is crucial for patient-centered care in complex medical situations.
Purpose of the Study:
- To propose a practical framework for shared decision making (SDM) in cardio-oncology.
- To support physicians in navigating difficult treatment decisions with patients.
- To enhance patient participation and align treatment with patient values and goals.
Main Methods:
- Drawing upon clinical practice experience in cardio-oncology.
- Implementing a longitudinal, multidisciplinary approach to SDM.
- Focusing on patient values and goals in treatment selection.
Main Results:
- A practical framework for SDM in cardio-oncology has been developed.
- The framework facilitates active physician-patient participation in decision-making.
- This approach aims to improve outcomes from the patient's perspective.
Conclusions:
- Shared decision making (SDM) is essential for patients facing complex cardio-oncology decisions.
- A structured framework can guide physicians and patients toward mutually agreeable treatment plans.
- Prioritizing patient values and goals leads to better outcomes in advanced malignancy care.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease IV: Preventive Measures
Ethical Dilemmas II
